Prevalence of extraintestinal manifestations of IBD
| CD | UC | Total | ||||
| n | %* | n | %† | n | %‡ | |
| Arthropathy and arthritis | 33 | 17.0 | 29 | 25.0 | 62 | 20.0 |
| Metabolic bone disease | 6 | 3.1 | 8 | 6.9 | 14 | 4.5 |
| Eye disease | 5 | 2.6 | 5 | 4.3 | 10 | 3.2 |
| Oral, aural and nasal disease | 3 | 1.5 | 2 | 1.7 | 5 | 1.6 |
| Skin disease | 17 | 8.8 | 7 | 6.0 | 24 | 7.7 |
| Hepato-pancreato-biliary disease | 0 | 0 | 1 | 0.9 | 1 | 0.3 |
| Neurological disease | 0 | 0 | 2 | 1.7 | 2 | 0.6 |
| Cardiovascular manifestations of IBD | 0 | 0 | 0 | 0 | 0 | 0 |
| Pulmonary manifestations of IBD | 0 | 0 | 0 | 0 | 0 | 0 |
| Genitourinary manifestations | 1 | 0.5 | 0 | 0 | 1 | 0.3 |
*Percentages calculated over 194 patients with CD.
†Percentages calculated over 116 patients with UC.
‡Percentages calculated over 310 patients.
CD, Crohn’s disease; IBD, inflammatory bowel disease; UC, ulcerative colitis.